Sang Froid labs India receives drug license
Sang Froid labs India has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified in Schedules C and C(1) [excluding those specified In schedule x] as per the Drugs and Cosmetics Rules, 1945 in form 21B and the company has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified Other Than Those Specified in Schedules C and C(1) and in schedule x as per the Drugs and Cosmetics Rules, 1945 in form 20B at the premises situated at F-118, Signature Complex ,Sur No.340, TP No.38, FP no. 223,224 Opposite Suvarna Bung, 100 Ft Hebatpur Road, Thaltej, Ahmedabad, Further the license shall be in force from October 12, 2018 to October 11, 2023.
The main objects of the company for which it was incorporated were to import/export , buy/ and deal in pharmaceutical medicines, drug intermediates, bulk drugs, medical preparations, surgical instruments, X-ray equipments, cat scanner, ultrasound equipments, blood testing equipments and all other hospital related equipment.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.